18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy

NCT01991977 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

91

Enrollment

OTHER

Sponsor class

Conditions

Malignant Glioma

Interventions

PROCEDURE: Diffusion Weighted Imaging
DRUG: Fluorine F 18 Fluorodopa
RADIATION: Intensity-Modulated Radiation Therapy
PROCEDURE: Perfusion Magnetic Resonance Imaging
PROCEDURE: Positron Emission Tomography
OTHER: Quality-of-Life Assessment
DRUG: Temozolomide

Sponsor

Mayo Clinic